Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALT
CTNM
Add up to 3 more stocks
ALT
Altimmune, Inc.
-0.37%
$2.66-0.01Delayed quote: Oct 6, 2026, 3:25 PM EDT
Market Cap
$517.30M
52W Range
$2.56 - $6.44
CTNM
Contineum Therapeutics, Inc.
-0.86%
$12.61-0.11Delayed quote: Oct 6, 2026, 3:25 PM EDT
Market Cap
$474.40M
52W Range
$8.60 - $17.79
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.09 | 1.98 |
| P/S Ratio | 16687.12 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | -230461.0% | 0.0% |
| Net Margin | -296000.0% | 0.0% |
| ROE | -19.4% | -24.0% |
| ROA | -17.4% | -23.0% |
| ROIC | -19.5% | -27.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 26.78 | 37.17 |
| Quick Ratio | 26.78 | 37.17 |
| Debt/Equity | 0.08 | 0.03 |
| Interest Coverage | -57.76 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.